Quantitative Correlations Among CYP3A Sensitive Substrates and Inhibitors:Literature Analysis

Author(s): Isabelle Ragueneau-Majlessi, Xavier Boulenc, Clemence Rauch, Houda Hachad, Rene H. Levy

Journal Name: Current Drug Metabolism

Volume 8 , Issue 8 , 2007


Become EABM
Become Reviewer
Call for Editor

Abstract:

As a follow-up to the new classification of CYP3A inhibitors, the present work was undertaken to search for quantitative correlations of AUC ratios between sensitive substrates and midazolam (reference). A large set of clinical studies was obtained utilizing the M Drug Interaction Database™, and recent Product Labels. Linear relationships were found between midazolam and four CYP3A substrates: simvastatin, buspirone, triazolam and eplerenone. Simvastatin and buspirone were consistently more sensitive than midazolam, independent of the inhibitor. Quantitative correlations of AUC ratios between four CYP3A inhibitors (fluconazole, erythromycin, verapamil, diltiazem) and ketoconazole (400 mg/day) were also uncovered. The average potencies of these inhibitors relative to ketoconazole were 27% for erythromycin, 17% for fluconazole and 19% for verapamil.

Keywords: Cytochrome P450 CYP3A, drug-drug interactions, inhibition

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 8
Year: 2007
Page: [810 - 814]
Pages: 5
DOI: 10.2174/138920007782798135
Price: $65

Article Metrics

PDF: 12